Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03548233Unknown
Open-label trial of bcg vaccine in Tuberculosis (TB), sponsored by Assiut University. Primary endpoints: Frequency of children without BCG scar at 1 year, Factors affecting BCG scar formation at 1 year and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03548233.